Published in Altern Med Rev on September 01, 2011
Herbal products: benefits, limits, and applications in chronic liver disease. Evid Based Complement Alternat Med (2012) 0.86
An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study. Drug Metab Dispos (2013) 0.85
Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality? Oxid Med Cell Longev (2016) 0.80
The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity. Drug Metab Dispos (2014) 0.80
Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery. Int J Nanomedicine (2015) 0.77
Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles. Int J Pharm Investig (2014) 0.77
Crepidiastrum denticulatum extract protects the liver against chronic alcohol-induced damage and fat accumulation in rats. J Med Food (2014) 0.75
Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity. BMC Complement Altern Med (2015) 0.75
Optimization and single-laboratory validation of a method for the determination of flavonolignans in milk thistle seeds by high-performance liquid chromatography with ultraviolet detection. Anal Bioanal Chem (2015) 0.75
Glycogen-gold nanohybrid escalates the potency of silymarin. Int J Nanomedicine (2017) 0.75
Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm (2006) 1.59
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm (2007) 1.48
Design and evaluation of bilayer floating tablets of captopril. Acta Pharm (2006) 1.41
Formulation development and optimization using nanoemulsion technique: a technical note. AAPS PharmSciTech (2007) 1.39
Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm Allergy Drug Targets (2009) 1.28
Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces (2009) 1.22
Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. AAPS PharmSciTech (2010) 1.12
Strategy for effective brain drug delivery. Eur J Pharm Sci (2010) 1.03
Advancement in carbon nanotubes: basics, biomedical applications and toxicity. J Pharm Pharmacol (2010) 0.99
Physicochemical characterization, in vitro dissolution behavior, and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. preparation and properties of rofecoxib hydroxypropyl beta-cyclodextrin inclusion complex: a technical note. AAPS PharmSciTech (2005) 0.99
Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech (2006) 0.96
Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B Biointerfaces (2011) 0.93
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies. J Pharm Sci (2003) 0.93
Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm (2010) 0.91
Effect of Cissampelos pareira root extract on isoproterenol-induced cardiac dysfunction. J Nat Med (2012) 0.90
Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil. Colloids Surf B Biointerfaces (2008) 0.90
Chemical penetration enhancers: a patent review. Expert Opin Ther Pat (2009) 0.88
Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm (2008) 0.88
Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy. Biomed Pharmacother (2012) 0.88
Isoflavonoids from Flemingia strobilifera (L) R. Br. roots. Acta Pol Pharm (2009) 0.87
Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des (2010) 0.87
Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J Drug Target (2010) 0.86
Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron. AAPS PharmSciTech (2009) 0.86
Microemulsions as potential drug delivery systems: a review. PDA J Pharm Sci Technol (2008) 0.86
Bioavailability enhancement of coenzyme Q10: an extensive review of patents. Recent Pat Drug Deliv Formul (2010) 0.84
Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies. Drug Dev Ind Pharm (2003) 0.83
Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug. PDA J Pharm Sci Technol (2008) 0.83
Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box-Behnken statistical design. J Pharm Sci (2011) 0.83
Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers. Pharm Dev Technol (2008) 0.83
Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections. AAPS PharmSciTech (2007) 0.83
Local delivery of minocycline hydrochloride: a therapeutic paradigm in periodontal diseases. Curr Drug Deliv (2010) 0.83
In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol (2008) 0.83
Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine (2011) 0.82
A study of the chemical composition of black cumin oil and its effect on penetration enhancement from transdermal formulations. Nat Prod Res (2010) 0.82
Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm (2013) 0.81
Novel buccal adhesive system for anti-hypertensive agent nimodipine. Pharm Dev Technol (2010) 0.81
Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Deliv (2010) 0.81
Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv (2011) 0.79
Development of HPTLC method for the estimation of ondansetron hydrochloride in bulk drug and sublingual tablets. Drug Test Anal (2011) 0.79
Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv (2013) 0.79
Chitosan-based gastroretentive floating drug delivery technology: an updated review. Expert Opin Drug Deliv (2012) 0.79
Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm (2013) 0.78
Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations. Pharm Dev Technol (2013) 0.78
Potential of microemulsions in drug delivery and therapeutics: a patent review. Recent Pat Drug Deliv Formul (2008) 0.77
Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats. Phytother Res (2011) 0.77
Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm (2011) 0.77
Lipid drug conjugate nanoparticle as a novel lipid nanocarrier for the oral delivery of decitabine: ex vivo gut permeation studies. Nanotechnology (2013) 0.77
Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone). J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.77
Intranasal administration of nanostructured lipid carriers containing CNS acting drug: pharmacodynamic studies and estimation in blood and brain. J Psychiatr Res (2012) 0.76
Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin Drug Deliv (2014) 0.76
Patents on nanoparticulate drug delivery systems--a review. Recent Pat Drug Deliv Formul (2008) 0.76
Nano-transfersomes as a novel carrier for transdermal delivery. Int J Pharm (2013) 0.76
Topical tacrolimus nanoemulsion, a promising therapeutic approach for uveitis. Med Hypotheses (2013) 0.76
Development and validation of a stability-indicating method for determination of free sterols in the Asian medicinal leech Hirudo manillensis. J Chromatogr Sci (2012) 0.75
Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats. Pharm Dev Technol (2005) 0.75
In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator. Arch Pharm Res (2011) 0.75
Effect of pre-treatment of almond oil on ultraviolet B-induced cutaneous photoaging in mice. J Cosmet Dermatol (2007) 0.75
Development and evaluation of transdermal patches of celecoxib. PDA J Pharm Sci Technol (2010) 0.75
Patented bioavailability enhancement techniques of silymarin. Recent Pat Drug Deliv Formul (2010) 0.75
Polyoliposomes: novel polyol-modified lipidic nanovesicles for dermal and transdermal delivery of drugs. Nanotechnology (2020) 0.75
The solution, solid state stability and kinetic investigation in degradation studies of lercanidipine: study of excipients compatibility of lercanidipine. Pharm Dev Technol (2011) 0.75
Design, development and evaluation of chronomodulated drug delivery systems of amoxicillin trihydrate with enhanced antimicrobial activity. Curr Drug Deliv (2013) 0.75
Anal fissure nanocarrier of lercanidipine for enhanced transdermal delivery: formulation optimization, ex vivo and in vivo assessment. Expert Opin Drug Deliv (2014) 0.75
Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator. Comb Chem High Throughput Screen (2011) 0.75
Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood. Drug Deliv (2013) 0.75
Recent advances and patent perspectives in gastroretentive technology. Recent Pat Drug Deliv Formul (2012) 0.75
Recent advances in gastric floating drug delivery technology: a review. Curr Drug Deliv (2013) 0.75
Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension. Drug Deliv (2010) 0.75
Isoproterenol-induced cardiomyopathy in rats: influence of Acorus calamus Linn.: A. calamus attenuates cardiomyopathy. Cardiovasc Toxicol (2011) 0.75